Managing Director
Phone: 203.569.6800
Fax: 203.569.6891
dgershon@mmdillon.com
|
David Gershon
Dr. Gershon has over 20 years experience as an oncologist-immunologist, clinical researcher, healthcare economist, and FDAhealthcare regulatory attorney with expertise in drug and medical device approval processes, clinical research, and reimbursement for pharmaceuticals, medical devices, and healthcare services. He is the Senior Partner of Gershon Capital & Cie, a Swiss investment and advisory firm that provides transatlantic capital raising, M&A solutions, and business development,regulatory affairs and product commercialization, the Chairman of the National Institute for Healthcare Economics and Regulatory Policy, is a designated Standard & Poor's 'Healthcare Industry Leader', Adjunct Professor of Healthcare Economics and Policy at Johns Hopkins University, Visiting Lecturer of Healthcare Finance and Drug Development atHarvard University and MIT Sloan Business School, Assistant Professor of Healthcare Economics and Finance at Columbia University, and a former Aspen Institute Senior Fellow and Chair of the Aspen Institute Business of HealthProgram. Dr. Gershon provides Caris Dillon with a very deep domain expertise in medicine, science, life sciences research, regulatory affairs, and product commercialization as well as an extensive international network of investors in Europe, the Middle East, and Asia.
|
